Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies

References

• Evans M, Kaufman M. Establishment in culture of pluripotential cells from mouse embryos. Nature292, 154–156 (1981).
   PubMed Web of Science ®Google Scholar
• Joshi C, Enver T. Molecular complexities of stem cells. Curr. Opin Hematol.10(3), 220–228 (2003).
   PubMedGoogle Scholar
• Maltsev VA, Wobus AM, Rohwedel J, Bader M, Hescheler J. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ. Res.75(2), 233–244 (1994).
   PubMed Web of Science ®Google Scholar
• Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest.98(1), 216–224 (1996).
   PubMed Web of Science ®Google Scholar
• Narita N, Bielinska M, Wilson DB. Cardiomyocyte differentiation by GATA-4-deficient embryonic stem cells. Development124(19), 3755–3764 (1997).
   PubMed Web of Science ®Google Scholar
• Okabe S, Forsberg-Nilsson K, Spiro AC, Segal M, McKay RD. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev.59(1), 89–102 (1996).
   PubMed Web of Science ®Google Scholar
• Lee SH, Lumelsky N, Studer L, Auerbach JM, McKay RD. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol.18(6), 675–679 (2000).
   PubMed Web of Science ®Google Scholar
• Li M, Pevny L, Lovell-Badge R, Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol.8(17), 971–974 (1998).
   PubMed Web of Science ®Google Scholar
• Choi D, Oh HJ, Chang UJ et al.In vivo differentiation of mouse embryonic stem cells into hepatocytes. Cell Transplant.11(4), 359–368 (2002).
   PubMed Web of Science ®Google Scholar
• Hamazaki T, Iiboshi Y, Oka M et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett.497(1), 15–19 (2001).
   PubMed Web of Science ®Google Scholar
• Chinzei R, Tanaka Y, Shimizu-Saito K et al. Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes. Hepatology36(1), 22–29 (2002).
   PubMed Web of Science ®Google Scholar
• Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc. Natl Acad. Sci.99(15), 9864–9869 (2002).
   PubMed Web of Science ®Google Scholar
• Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat.200, 249–258 (2002).
   PubMed Web of Science ®Google Scholar
• Hori J, Ng TF, Shatos M et al. Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells21(4), 405–416 (2003).
   PubMed Web of Science ®Google Scholar
• Wu DC, Boyd AS, Wood KJ. Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack. Stem Cells26(8), 1939–1950 (2008).
   PubMedGoogle Scholar
• Boyd AS, Wood KJ. Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters. Transplantation87(9), 1300–1304 (2009).
   PubMedGoogle Scholar
• Mammolenti M, Gajavelli S, Tsoulfas P, Levy R. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro. Stem Cells22(6), 1101–1110 (2004).
   PubMed Web of Science ®Google Scholar
• Boyd AS, Higashi Y, Wood KJ. Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv. Drug Deliv. Rev.57(13), 1944–1969 (2005).
   PubMedGoogle Scholar
• Tian L, Catt J, O’Neill C et al. Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells. Biol. Reprod.57, 561–568 (1997).
   PubMedGoogle Scholar
• Robertson NJ, Brook FA, Gardner RL et al. Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc. Natl Acad. Sci. USA104(52), 20920–20925 (2007).
   PubMedGoogle Scholar
• Sprent J. Central tolerance of T cells. Int. Rev. Immunol.13(2), 95–105 (1995).
   PubMedGoogle Scholar
• Kisielow P, von Boehmer H. Development and selection of T cells: facts and puzzles. Adv. Immunol.58, 87–209 (1995).
   PubMedGoogle Scholar
• Grinnemo KH, Genead R, Kumagai-Braesch M et al. Costimulation blockade induces tolerance to HESC transplanted to the testis and induces regulatory T-cells to HESC transplanted into the heart. Stem Cells26(7), 1850–1857 (2008).
   PubMed Web of Science ®Google Scholar
• Gershon RK, Kondo K. Infectious immunological tolerance. Immunology21(6), 903–914 (1971).
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol.155(3), 1151–1164 (1995).
   PubMed Web of Science ®Google Scholar
• Kemper C, Chan AC, Green JM et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature421(6921), 388–392 (2003).
   PubMed Web of Science ®Google Scholar
• Groux H, O’Garra A, Bigler M et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature389(6652), 737–742 (1997).
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Emerging concepts in CD8+ T regulatory cells. Curr. Opin Immunol.20(3), 327–331 (2008).
   PubMed Web of Science ®Google Scholar
• Lu L, Cantor H. Generation and regulation of CD8+ regulatory T cells. Cell Mol. Immunol.5(6), 401–406 (2008).
   PubMed Web of Science ®Google Scholar
• Gilliet M, Liu YJ. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med.195(6), 695–704 (2002).
   PubMed Web of Science ®Google Scholar
• Faunce DE, Stein-Streilein J. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol.169(1), 31–38 (2002).
   PubMed Web of Science ®Google Scholar
• Hayday A, Tigelaar R. Immunoregulation in the tissues by γδ T cells. Nat. Rev. Immunol.3(3), 233–242 (2003).
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med.188(2), 287–296 (1998).
   PubMed Web of Science ®Google Scholar
• Itoh M, Takahashi T, Sakaguchi N et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol.162(9), 5317–5326 (1999).
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kuniyasu Y, Toda M et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol.10(12), 1969–1980 (1998).
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol.167(3), 1245–1253 (2001).
   PubMed Web of Science ®Google Scholar
• Qin S, Cobbold SP, Pope H et al. ‘Infectious’ transplantation tolerance. Science259(5097), 974–977 (1993).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol.4(4), 330–336 (2003).
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.4(4), 337–342 (2003).
   PubMed Web of Science ®Google Scholar
• Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science299(5609), 1057–1061 (2003).
   PubMed Web of Science ®Google Scholar
• Gavin MA, Rasmussen JP, Fontenot JD et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature445(7129), 771–775 (2007).
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Rasmussen JP, Williams LM et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity22(3), 329–341 (2005).
   PubMed Web of Science ®Google Scholar
• Godfrey VL, Wilkinson JE, Russell LB. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol.138(6), 1379–1387 (1991).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet.27(1), 20–21 (2001).
   PubMed Web of Science ®Google Scholar
• Bennett CL, Brunkow ME, Ramsdell F et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA→AAUGAA) leads to the IPEX syndrome. Immunogenetics53(6), 435–439 (2001).
   PubMed Web of Science ®Google Scholar
• Morgan ME, van Bilsen JH, Bakker AM et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol.66(1), 13–20 (2005).
   PubMed Web of Science ®Google Scholar
• North TE, de Bruijn MF, Stacy T et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity16(5), 661–672 (2002).
   PubMed Web of Science ®Google Scholar
• Yokomizo T, Ogawa M, Osato M et al. Requirement of Runx1/AML1/PEBP2aB for the generation of haematopoietic cells from endothelial cells. Genes Cells6(1), 13–23 (2001).
   PubMed Web of Science ®Google Scholar
• Kitoh A, Ono M, Naoe Y et al. Indispensable role of the Runx1-Cbfβ transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity31(4), 609–620 (2009).
   PubMed Web of Science ®Google Scholar
• Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature446(7136), 685–689 (2007).
   PubMed Web of Science ®Google Scholar
• Klunker S, Chong MMW, Mantel P-Y et al. Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells. J. Exp. Med.206(12), 2701–2715 (2009).
   PubMed Web of Science ®Google Scholar
• Gurdon JB. Adult frogs derived from the nuclei of single somatic cells. Dev. Biol.4, 256–273 (1962).
   PubMed Web of Science ®Google Scholar
• Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature380(6569), 64–66 (1996).
   PubMed Web of Science ®Google Scholar
• Cibelli JB, Stice SL, Golueke PJ et al. Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat. Biotechnol.16(7), 642–646 (1998).
   PubMed Web of Science ®Google Scholar
• Wakayama T, Tabar V, Rodriguez I et al. Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science292(5517), 740–743 (2001).
   PubMed Web of Science ®Google Scholar
• Rideout W, Hochedlinger K, Kyba M, Daley G, Jaenisch R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell109, 17–27 (2002).
   PubMed Web of Science ®Google Scholar
• Cibelli JB, Kiessling AA, Cunniff K et al. Somatic cell nuclear transfer in humans: pronuclear and early embryonic development. J. Regen. Med.2, 25–31 (2001).
   Google Scholar
• St John JC, Lloyd REI, Bowles EJ, Thomas EC, El Shourbagy S. The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective. Reproduction127(6), 631–641 (2004).
   PubMedGoogle Scholar
• Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science318(5858), 1920–1923 (2007).
   PubMed Web of Science ®Google Scholar
• Aarli JA. The immune system and the nervous system. J. Neurol.229(3), 137–154 (1983).
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. The immune privilege of corneal grafts. J. Leukoc. Biol.74(2), 167–171 (2003).
   PubMedGoogle Scholar
• Paus R, Ito N, Takigawa M, Ito T. The hair follicle and immune privilege. J. Investig. Dermatol. Symp. Proc.8(2), 188–194 (2003).
   PubMed Web of Science ®Google Scholar
• Bellgrau D, Gold D, Selawry H et al. A role for CD95 ligand in preventing graft rejection. Nature377(6550), 630–632 (1995).
   PubMed Web of Science ®Google Scholar
• Pollack IF, Lund RD. The blood–brain barrier protects foreign antigens in the brain from immune attack. Exp. Neurol.108(2), 114–121 (1990).
   PubMedGoogle Scholar
• Weetman AP. The immunology of pregnancy. Thyroid9(7), 643–646 (1999).
   PubMed Web of Science ®Google Scholar
• Wilbanks GA, Streilein JW. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol.22(4), 1031–1036 (1992).
   PubMedGoogle Scholar
• Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the foetus. Nat. Immunol.5(3), 266–271 (2004).
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science281(5380), 1191–1193 (1998).
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today20(10), 469–473 (1999).
   PubMedGoogle Scholar
• Munn DH, Sharma MD, Baban B et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity22(5), 633–642 (2005).
   PubMed Web of Science ®Google Scholar
• Cobbold SP, Adams E, Graca L et al. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev.213, 239–255 (2006).
   PubMed Web of Science ®Google Scholar
• Muller AJ, Scherle PA. Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors. Nat. Rev. Cancer6(8), 613–625 (2006).
   PubMed Web of Science ®Google Scholar
• Quan J, Tan PH, MacDonald A, Friend PJ. Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges. Expert Opin Biol. Ther.8(11), 1705–1719 (2008).
   PubMed Web of Science ®Google Scholar
• Cobbold SP, Adams E, Farquhar CA et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc. Natl Acad. Sci. USA106(29), 12055–12060 (2009).
   PubMed Web of Science ®Google Scholar
• Norian LA, Rodriguez PC, O’Mara LA et al. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res.69(7), 3086–3094 (2009).
   PubMed Web of Science ®Google Scholar
• Li L, Baroja ML, Majumdar A et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells22(4), 448–456 (2004).
   PubMed Web of Science ®Google Scholar
• Magliocca JF, Held IK, Odorico JS. Undifferentiated murine embryonic stem cells cannot induce portal tolerance but may possess immune privilege secondary to reduced major histocompatibility complex antigen expression. Stem Cells Dev.15(5), 707–717 (2006).
   PubMedGoogle Scholar
• Drukker M, Katchman H, Katz G et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells24(2), 221–229 (2006).
   PubMed Web of Science ®Google Scholar
• Cody AK, Pedro G, Jeffrey LP. Immunosuppression by embryonic stem cells. Stem Cells26(1), 89–98 (2008).
   PubMedGoogle Scholar
• Swijnenburg RJ, Schrepfer S, Govaert JA et al. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl Acad. Sci. USA105(35), 12991–12996 (2008).
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Deriglasova UF, Kulagina NN et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp. Hematol.2(2), 83–92 (1974).
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ. Precursor cells of mechanocytes. Int. Rev. Cytol.47, 327–359 (1976).
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science284(5411), 143–147 (1999).
   PubMed Web of Science ®Google Scholar
• Bianco P, Robey PG. Marrow stromal stem cells. J. Clin. Invest.105(12), 1663–1668 (2000).
   PubMed Web of Science ®Google Scholar
• Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy11(4), 377–391 (2009).
   PubMed Web of Science ®Google Scholar
• Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J. Hematother. Stem Cell Res.9(6), 841–848 (2000).
   PubMedGoogle Scholar
• Zhao RC, Liao L, Han Q. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. J. Lab. Clin. Med.143(5), 284–291 (2004).
   PubMedGoogle Scholar
• Kadereit S, Deeds LS, Haynesworth SE et al. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34+ CD38- early progenitors cultured over human MSCs as a feeder layer. Stem Cells20(6), 573–582 (2002).
   PubMed Web of Science ®Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood99(10), 3838–3843 (2002).
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol.30(1), 42–48 (2002).
   PubMed Web of Science ®Google Scholar
• Aksu AE, Horibe E, Sacks J et al. Coinfusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats. Clin. Immunol.127(3), 348–358 (2008).
   PubMedGoogle Scholar
• Oh JY, Kim MK, Shin MS et al. The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury. Stem Cells26(4), 1047–1055 (2008).
   PubMed Web of Science ®Google Scholar
• Meisel R, Zibert A, Laryea M et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood103(12), 4619–4621 (2004).
   PubMed Web of Science ®Google Scholar
• Sato K, Ozaki K, Oh I et al. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood109(1), 228–234 (2007).
   PubMed Web of Science ®Google Scholar
• Chabannes D, Hill M, Merieau E et al. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood110(10), 3691–3694 (2007).
   PubMed Web of Science ®Google Scholar
• Rafei M, Campeau PM, Aguilar-Mahecha A et al. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol.182(10), 5994–6002 (2009).
   PubMed Web of Science ®Google Scholar
• Lanza C, Morando S, Voci A et al. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. J. Neurochem.110(5), 1674–1684 (2009).
   PubMed Web of Science ®Google Scholar
• Rafei M, Hsieh J, Fortier S et al. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood112(13), 4991–4998 (2008).
   PubMedGoogle Scholar
• Hayashi Y, Tsuji S, Tsujii M et al. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J. Pharmacol. Exp. Ther.326(2), 523–531 (2008).
   PubMed Web of Science ®Google Scholar
• Tanaka F, Tominaga K, Ochi M et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci.83(23–24), 771–779 (2008).
   PubMed Web of Science ®Google Scholar
• Zappia E, Casazza S, Pedemonte E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood106(5), 1755–1761 (2005).
   PubMed Web of Science ®Google Scholar
• Ge W, Jiang J, Baroja ML et al. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am. J. Transplant.9(8), 1760–1772 (2009).
   PubMedGoogle Scholar
• Casiraghi F, Azzollini N, Cassis P et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J. Immunol.181(6), 3933–3946 (2008).
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet363(9419), 1439–1441 (2004).
   PubMed Web of Science ®Google Scholar
• Bolanos-Meade J, Vogelsang GB. Novel strategies for steroid-refractory acute graft-versus-host disease. Curr. Opin. Hematol.12(1), 40–44 (2005).
   PubMedGoogle Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4), 663–676 (2006).
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotech.26(1), 101–106 (2008).
   PubMed Web of Science ®Google Scholar
• Shi Y, Desponts C, Do JT et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell3(5), 568–574 (2008).
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131(5), 861–872 (2007).
   PubMed Web of Science ®Google Scholar
• Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science318(5858), 1917–1920 (2007).
   PubMed Web of Science ®Google Scholar
• Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science321(5889), 699–702 (2008).
   PubMed Web of Science ®Google Scholar
• Stadtfeld M, Brennand K, Hochedlinger K. Reprogramming of pancreatic b cells into induced pluripotent stem cells. Curr. Biol.18(12), 890–894 (2008).
   PubMed Web of Science ®Google Scholar
• Hanna J, Markoulaki S, Schorderet P et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell133(2), 250–264 (2008).
   PubMed Web of Science ®Google Scholar
• Choi KD, Yu J, Smuga-Otto K et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells27(3), 559–567 (2009).
   PubMed Web of Science ®Google Scholar
• Eminli S, Foudi A, Stadtfeld M et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet.41, 968–976 (2009).
   PubMed Web of Science ®Google Scholar
• Aasen T, Raya A, Barrero MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol.26(11), 1276–1284 (2008).
   PubMed Web of Science ®Google Scholar
• Ye Z, Zhan H, Mali P et al. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood114(27), 5409–5410. (2009).
   PubMedGoogle Scholar
• Yusa K, Rad R, Takeda J, Bradley A. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat. Methods6(5), 363–369 (2009).
   PubMed Web of Science ®Google Scholar
• Lyssiotis CA, Foreman RK, Staerk J et al. Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl Acad. Sci.106(22), 8912–8917 (2009).
   PubMed Web of Science ®Google Scholar
• Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell4(5), 381–384 (2009).
   PubMed Web of Science ®Google Scholar
• Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science322(5903), 949–953 (2008).
   PubMed Web of Science ®Google Scholar
• Woltjen K, Michael IP, Mohseni P et al. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature458(7239), 766–770 (2009).
   PubMed Web of Science ®Google Scholar
• Park I-H, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell134(5), 877–886 (2008).
   PubMed Web of Science ®Google Scholar
• Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science321(5893), 1218–1221 (2008).
   PubMed Web of Science ®Google Scholar
• Maehr R, Chen S, Snitow M et al. Generation of pluripotent stem cells from patients with type 1 diabetes. Proc. Natl Acad. Sci. USA106(37), 15768–15773 (2009).
   PubMed Web of Science ®Google Scholar
• Raya A, Rodriguez-Piza I, Guenechea G et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature460(7251), 53–59 (2009).
   PubMed Web of Science ®Google Scholar
• Miura K, Okada Y, Aoi T et al. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotech.27(8), 743–745 (2009).
   PubMed Web of Science ®Google Scholar
• Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell5(1), 111–123 (2009).
   Google Scholar
• Karumbayaram S, Novitch BG, Patterson M et al. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells27(4), 806–811 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang J, Wilson GF, Soerens AG et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res.104(4), e30–e41 (2009).
   PubMed Web of Science ®Google Scholar
• Scherer M, Banas B, Mantouvalou K et al. Current concepts and perspectives of immunosuppression in organ transplantation. Langenbeck’s Arch. Surg.392(5), 511–523 (2007).
   PubMed Web of Science ®Google Scholar
• McEwan A, Petty LG. Oncogenicity of immunosuppressive drugs. Lancet1(7745), 326–327 (1972).
   PubMedGoogle Scholar
• Dunn DL. Hazardous crossing: immunosuppression and nosocomial infections in solid organ transplant recipients. Surg. Infect. (Larchmt)2(2), 103–110; discussion 110–102 (2001).
   PubMedGoogle Scholar
• Lechler R and Batchelor J. Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J. Exp. Med.156, 1835–1841 (1982).
   PubMed Web of Science ®Google Scholar
• Sharabi Y, Aksentijevich I, Sundt TM 3rd, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J. Exp. Med.172(1), 195–202 (1990).
   PubMedGoogle Scholar
• Gibbons C, Sykes M. Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism. Immunol. Rev.223, 334–360 (2008).
   PubMedGoogle Scholar
• Tosi P, Kraft R, Luzi P et al. Involution patterns of the human thymus. I. Size of the cortical area as a function of age. Clin. Exp. Immunol.47(2), 497–504 (1982).
   PubMedGoogle Scholar
• Hale JS, Boursalian TE, Turk GL, Fink PJ. Thymic output in aged mice. Proc. Natl Acad. Sci. USA103(22), 8447–8452 (2006).
   PubMed Web of Science ®Google Scholar
• Cunningham CP, Kimpton WG, Holder JE, Cahill RN. Thymic export in aged sheep: a continuous role for the thymus throughout pre- and postnatal life. Eur. J. Immunol.31(3), 802–811 (2001).
   PubMedGoogle Scholar
• Cowan DF. Involution and cystic transformation of the thymus in the bottlenose dolphin, Tursiops truncatus. Vet. Pathol.31(6), 648–653 (1994).
   PubMedGoogle Scholar
• Steinmann GG. Changes in the human thymus during aging. Curr. Top. Pathol.75, 43–88 (1986).
   PubMedGoogle Scholar
• Hickman SP, Turka LA. Homeostatic T cell proliferation as a barrier to T cell tolerance. Philos. Trans. R. Soc. Lond. B. Biol. Sci.360(1461), 1713–1721 (2005).
   PubMed Web of Science ®Google Scholar
• Long B, Wong CP, Wang Y, Tisch R. Lymphopenia-driven CD8+ T cells are resistant to antigen-induced tolerance in NOD.scid mice. Eur. J. Immunol.36(8), 2003–2012 (2006).
   PubMedGoogle Scholar
• Chen W, Jin W, Hardegen N et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med.198(12), 1875–1886 (2003).
   PubMed Web of Science ®Google Scholar
• Peng Y, Laouar Y, Li MO, Green EA, Flavell RA. TGF-β regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl Acad. Sci. USA101(13), 4572–4577 (2004).
   PubMed Web of Science ®Google Scholar
• Mucida D, Park Y, Kim G et al. Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science317(5835), 256–260 (2007).
   PubMed Web of Science ®Google Scholar
• Elias KM, Laurence A, Davidson TS et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood111(3), 1013–1020 (2008).
   PubMed Web of Science ®Google Scholar
• Mucida D, Pino-Lagos K, Kim G et al. Retinoic acid can directly promote TGF-β-mediated Foxp3+ Treg cell conversion of naive T cells. Immunity30(4), 471–472 (2009).
   PubMed Web of Science ®Google Scholar
• Coombes JL, Siddiqui KRR, Arancibia-Carcamo CV et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid dependent mechanism. J. Exp. Med.204(8), 1757–1764 (2007).
   PubMed Web of Science ®Google Scholar
• Hill JA, Hall JA, Sun C-M et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity29(5), 758–770 (2008).
   PubMed Web of Science ®Google Scholar
• Fairchild PJ, Waldmann H. Dendritic cells and the prospects for transplantation tolerance. Curr. Opin Immunol.12, 528 (2000).
   PubMed Web of Science ®Google Scholar
• Hackstein H, Morelli AE, Thomson AW. Designer dendritic cells for tolerance induction: guided not mis-guided missiles. Trends Immunol.22, 437 (2001).
   PubMed Web of Science ®Google Scholar
• Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol.80(5), 477–483 (2002).
   PubMed Web of Science ®Google Scholar
• Yates SF, Paterson AM, Nolan KF et al. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J. Immunol.179(2), 967–976 (2007).
   PubMed Web of Science ®Google Scholar
• Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol.2(11), 1010–1017 (2001).
   PubMed Web of Science ®Google Scholar
• Keir ME, Liang SC, Guleria I et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med.203(4), 883–895 (2006).
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Akiba H, Iwai H et al. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol.169(10), 5538–5545 (2002).
   PubMed Web of Science ®Google Scholar
• Ishida M, Iwai Y, Tanaka Y et al. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett.84(1), 57–62 (2002).
   PubMed Web of Science ®Google Scholar
• Fife BT, Pauken KE, Eagar TN et al. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol.10(11), 1185–1192 (2009).
   PubMed Web of Science ®Google Scholar
• Chikuma S, Imboden JB, Bluestone JA. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med.197(1), 129–135 (2003).
   PubMed Web of Science ®Google Scholar
• Dustin ML, Bromley SK, Kan Z, Peterson DA, Unanue ER. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc. Natl Acad. Sci. USA94(8), 3909–3913 (1997).
   PubMed Web of Science ®Google Scholar
• Fadok VA, Bratton DL, Konowal A et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J. Clin. Invest.101(4), 890–898 (1998).
   PubMed Web of Science ®Google Scholar
• Chen W, Frank ME, Jin W, Wahl SM. TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity14(6), 715–725 (2001).
   PubMed Web of Science ®Google Scholar
• Kushwah R, Oliver JR, Zhang J, Siminovitch KA, Hu J. Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J. Immunol.183(11), 7104–7118 (2009).
   PubMedGoogle Scholar
• Penna G, Adorini L. 1 a,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol.164(5), 2405–2411 (2000).
   PubMed Web of Science ®Google Scholar
• Fairchild PJ, Brook FA, Gardner RL et al. Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr. Biol.10, 1515–1518 (2000).
   PubMed Web of Science ®Google Scholar
• Fairchild PJ, Nolan KF, Waldmann H. Genetic modification of dendritic cells through the directed differentiation of embryonic stem cells. Methods Mol. Biol.380, 59–72 (2007).
   PubMedGoogle Scholar
• Fairchild PJ, Nolan KF, Cartland S, Waldmann H. Embryonic stem cells: a novel source of dendritic cells for clinical applications. Int. Immunopharmacol.5(1), 13–21 (2005).
   PubMed Web of Science ®Google Scholar
• Zhan X, Dravid G, Ye Z et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet364(9429), 163–171 (2004).
   PubMed Web of Science ®Google Scholar
• Slukvin, II, Vodyanik MA, Thomson JA, Gumenyuk ME, Choi KD. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J. Immunol.176(5), 2924–2932 (2006).
   PubMedGoogle Scholar
• Su Z, Frye C, Bae KM, Kelley V, Vieweg J. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions. Clin. Cancer Res.14(19), 6207–6217 (2008).
   PubMedGoogle Scholar
• Senju S, Haruta M, Matsunaga Y et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells27(5), 1021–1031 (2009).
   PubMedGoogle Scholar
• Bandi S, Akkina R. Human embryonic stem cell (hES) derived dendritic cells are functionally normal and are susceptible to HIV-1 infection. AIDS Res. Ther.5, 1 (2008).
   PubMedGoogle Scholar
• Senju S, Suemori H, Zembutsu H et al. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Stem Cells25(11), 2720–2729 (2007).
   PubMedGoogle Scholar
• Tseng SY, Nishimoto KP, Silk KM et al. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. Regen. Med.4(4), 513–526 (2009).
   PubMed Web of Science ®Google Scholar
• Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science322(5903), 945–949 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JB, Sebastiano V, Wu G et al. Oct4-induced pluripotency in adult neural stem cells. Cell136(3), 411–419 (2009).
   PubMed Web of Science ®Google Scholar